Delivery Order SPE2DB24D2013-SPE2DB25FCJUY
Award Date 8/5/25
Potential Completion Date 8/26/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of BOSULIF 400 mg tablets (30-count packages) with a ceiling value of $23,631.26. The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $11,815.63 and completion deadline of August 29, 2025. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a prescription oncology...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOSULIF 100 mg tablets (120-count) valued at $11,408.90 on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. BOSULIF (bosutinib) is a targeted cancer therapy used in the treatment of chronic myeloid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $5,704.45. This firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency (DLA) awarded a $4,991.27 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply BOSULIF 100 MG TABLET 120S. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC is the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,047.42, is to deliver 120 units of the prescription drug BOSULIF 100 mg tablets. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This delivery order, awarded July 28, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 120 tablets of Bosulif 100 mg with a ceiling value of $5,704.45 and a firm fixed price structure. The order is scheduled for completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger indefinite delivery contract vehicle that...
- This is a $11,815.63 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5.7K to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a tyrosine kinase inhibitor used in oncology treatment. The contract was competitively awarded without set-aside provisions under firm fixed pricing terms, with performance at the vendor's Conshohocken, Pennsylvania location and an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...